COVID-19 tweets from November 2020 have come back to haunt Pfizer once again. Fourteen months after an old tweet caused Pfizer new problems, pandemic-era social media posts linked to the drugmaker ...
President Donald Trump demanded that pharmaceutical companies release data pertaining to the success rates of their Covid "drugs" in order to clear up the discrepancy "mess" over the products, though ...
The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...
Collage image of a gloved hand holding pill, with a masked, coughing patient in the background. Credit: Madeline Monroe/C&EN/Shutterstock Avindra Nath believes he has ...
Years after the biopharmaceutical industry stepped up to create COVID-19 vaccines as the virus spiraled into a global pandemic, federal prosecutors are shining a light on a long-disputed political ...
Traws Pharma, Inc. announced promising results for ratutrelvir, a main protease inhibitor for COVID-19, suggesting it can be administered without ritonavir, potentially reducing the risk of drug ...
Ratutrelvir shows a differentiated profile versus PAXLOVID™ with fewer adverse events and no viral rebounds Activity shown in Paxlovid ®-ineligible patients, representing a significant population with ...
BRUSSELS (AP) — Text messages exchanged between European Commission President Ursula von der Leyen and a pharmaceutical boss during the COVID-19 pandemic were seen by her top adviser and have likely ...
Dr. Makary’s right-hand man at the FDA, Dr. Vinay Prasad, has long expressed similar thoughts, writing: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback